CA3100706A1 - Synthesis of tipifarnib - Google Patents

Synthesis of tipifarnib Download PDF

Info

Publication number
CA3100706A1
CA3100706A1 CA3100706A CA3100706A CA3100706A1 CA 3100706 A1 CA3100706 A1 CA 3100706A1 CA 3100706 A CA3100706 A CA 3100706A CA 3100706 A CA3100706 A CA 3100706A CA 3100706 A1 CA3100706 A1 CA 3100706A1
Authority
CA
Canada
Prior art keywords
tipifarnib
mixture
racemic
formula
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3100706A
Other languages
English (en)
French (fr)
Inventor
Pingda Ren
Xiaohu Deng
Wanping MAI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kura Oncology Inc
Original Assignee
Kura Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kura Oncology Inc filed Critical Kura Oncology Inc
Publication of CA3100706A1 publication Critical patent/CA3100706A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA3100706A 2018-05-18 2019-05-17 Synthesis of tipifarnib Pending CA3100706A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862673693P 2018-05-18 2018-05-18
US62/673,693 2018-05-18
PCT/US2019/032765 WO2019222565A1 (en) 2018-05-18 2019-05-17 Synthesis of tipifarnib

Publications (1)

Publication Number Publication Date
CA3100706A1 true CA3100706A1 (en) 2019-11-21

Family

ID=66770583

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3100706A Pending CA3100706A1 (en) 2018-05-18 2019-05-17 Synthesis of tipifarnib

Country Status (13)

Country Link
US (1) US11542244B2 (https=)
EP (1) EP3793966A1 (https=)
JP (1) JP2021526513A (https=)
KR (1) KR20210039987A (https=)
CN (1) CN112424149B (https=)
AU (1) AU2019270163A1 (https=)
BR (1) BR112020023559A2 (https=)
CA (1) CA3100706A1 (https=)
EA (1) EA202092787A1 (https=)
MX (1) MX2020012305A (https=)
PH (1) PH12020551956A1 (https=)
SG (1) SG11202011378WA (https=)
WO (1) WO2019222565A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102839264B1 (ko) 2023-03-07 2025-07-29 단국대학교 천안캠퍼스 산학협력단 티피파르닙을 유효성분으로 포함하는 근감소증 예방 또는 치료용 약학 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214695T1 (de) 1994-09-23 2002-04-15 Darwin Discovery Ltd Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE69620445T2 (de) 1995-12-08 2002-12-12 Janssen Pharmaceutica N.V., Beerse (imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
BRPI0208075B8 (pt) * 2001-03-12 2021-05-25 Janssen Pharmaceutica Nv processo para a preparação de compostos de imidazol
DE602005007604D1 (de) * 2004-05-03 2008-07-31 Janssen Pharmaceutica Nv Diastereoselektive addition von lithiiertem n-methylimidazol an sulfinimine
JP5008554B2 (ja) * 2004-05-03 2012-08-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ イミダゾール化合物の製造用のジアステレオ選択的合成方法
CN100567291C (zh) * 2004-05-03 2009-12-09 詹森药业有限公司 用6-溴-4-(3-氯苯基)-2-甲氧基喹啉进行的非对映选择性合成方法
EP3221311B1 (en) * 2014-11-21 2019-10-30 Merck Patent GmbH Method for the production of praziquantel
CN104876856B (zh) 2015-05-05 2017-11-21 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑3‑氨基哌啶二盐酸盐的方法

Also Published As

Publication number Publication date
JP2021526513A (ja) 2021-10-07
PH12020551956A1 (en) 2021-08-16
US20210246114A1 (en) 2021-08-12
EA202092787A1 (ru) 2021-02-09
MX2020012305A (es) 2021-03-25
KR20210039987A (ko) 2021-04-12
AU2019270163A1 (en) 2020-12-03
CN112424149A (zh) 2021-02-26
CN112424149B (zh) 2023-06-23
EP3793966A1 (en) 2021-03-24
SG11202011378WA (en) 2020-12-30
US11542244B2 (en) 2023-01-03
WO2019222565A1 (en) 2019-11-21
BR112020023559A2 (pt) 2021-02-09

Similar Documents

Publication Publication Date Title
EP2526101B1 (en) Crystalline forms of a purine derivative
TWI630209B (zh) 光學活性二胺衍生物之鹽的製造方法
TWI693214B (zh) (2s,3s)7-氟-2-(4-氟苯基)-3-(1-甲基-1h-1,2,4-三唑-5-基)-4-側氧基-1,2,3,4-四氫喹啉-5-羧酸甲酯之共形成體鹽及其製備方法
WO2016102438A1 (en) Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidine analogues
WO2014157612A1 (ja) (1s,4s,5s)-4-ブロモ-6-オキサビシクロ[3.2.1]オクタン-7-オンの製造方法
CN104418841B (zh) 一种光学纯雷贝拉唑及其钠盐的制备方法
JP5654462B2 (ja) 貧溶媒添加法による2−(3−シアノ−4−イソブチルオキシフェニル)−4−メチル−5−チアゾールカルボン酸の結晶多形体の製造方法
EP4021576A1 (en) Isavuconazonium salts and process for preparing thereof
CA2719778C (en) Method for preparing argatroban monohydrate
US11542244B2 (en) Synthesis of tipifarnib
EP2041083B1 (en) Methods of preparing zofenopril calcium
TW201722950A (zh) 嗎啉衍生物的鹽及其晶型、其製備方法及藥物組成物、用途
EA042764B1 (ru) Способы получения (r)-(+)-типифарниба
WO2008093357A2 (en) Process for preparation of crystalline clopidogrel hydrogen sulphate form i
WO2015104602A2 (en) A process for the preparation of anagliptin and its intermediates thereof
JP4402361B2 (ja) 塩酸エピナスチンの結晶多形
KR101098031B1 (ko) 암로디핀 니코티네이트의 신규 결정형 및 이의 제조방법
CN118852050A (zh) 一种新型左旋咪唑中间体化合物及其制备方法和用途
CN107674072B (zh) 二氢嘧啶衍生物及其酸加成物的制备方法
JP5934004B2 (ja) 結晶構造を有する4−アミノ−2−メチル−10H−チエノ〔2,3−b〕〔1,5〕ベンゾジアゼピン塩酸塩水和物及びその製造方法
WO2018115181A1 (en) New salt of ivabradine and uses thereof
HK1236192B (zh) 一种共形成体盐及其制备方法
WO2014063752A1 (en) Process for making crystalline form alpha of eletriptan hydrobromide
WO2010068605A1 (en) Novel polymorphic forms of 4-[(4-methoxyphenyl)methyl]-5-(trifluoromethyl)-1h-pyrazole-3-yl]4-deoxy-4-fluoro-beta-d-glucopyranoside including hydrates thereof and the preparations thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220804